GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monivent AB (XSAT:MONI) » Definitions » Cash Flow from Financing

Monivent AB (XSAT:MONI) Cash Flow from Financing : kr6.57 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Monivent AB Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Monivent AB received kr10.92 Mil more from issuing new shares than it paid to buy back shares. It spent kr2.83 Mil paying down its debt. It paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received kr0.00 Mil from paying cash dividends to shareholders. It spent kr2.32 Mil on other financial activities. In all, Monivent AB earned kr5.76 Mil on financial activities for the three months ended in Mar. 2024.


Monivent AB Cash Flow from Financing Historical Data

The historical data trend for Monivent AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monivent AB Cash Flow from Financing Chart

Monivent AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Flow from Financing
Get a 7-Day Free Trial 6.68 1.88 30.87 6.33 12.06

Monivent AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.37 1.56 1.06 -0.25 5.76

Monivent AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Monivent AB's Cash from Financing for the fiscal year that ended in Dec. 2022 is calculated as:

Monivent AB's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monivent AB  (XSAT:MONI) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Monivent AB's issuance of stock for the three months ended in Mar. 2024 was kr10.92 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Monivent AB's repurchase of stock for the three months ended in Mar. 2024 was kr0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Monivent AB's net issuance of debt for the three months ended in Mar. 2024 was kr-2.83 Mil. Monivent AB spent kr2.83 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Monivent AB's net issuance of preferred for the three months ended in Mar. 2024 was kr0.00 Mil. Monivent AB paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Monivent AB's cash flow for dividends for the three months ended in Mar. 2024 was kr0.00 Mil. Monivent AB received kr0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Monivent AB's other financing for the three months ended in Mar. 2024 was kr-2.32 Mil. Monivent AB spent kr2.32 Mil on other financial activities.


Monivent AB Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Monivent AB's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Monivent AB (XSAT:MONI) Business Description

Traded in Other Exchanges
N/A
Address
Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.